Clinical Trial Update: A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating patient preference for convenience of SUGAMET XR Tablet 5/1000 mg and its efficacy/safety in type 2 diabetes, with renal dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• SUGAMET XR Tablet 5/1000mg (sugammadex? (Note: uncertain from provided data; placeholder))

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabetes Mellitus, Type 2, Renal Disease | Phase 4 | Status: UNKNOWN